[Drug therapy for self mutilators. Remarks and prospects].
D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001521:Behavior Therapy / Q000379:methods; D002648:Child; D006801:Humans; D007926:Lesch-Nyhan Syndrome / Q000188:drug therapy; D009292:Narcotic Antagonists / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012652:Self Mutilation / Q000188:drug therapy*; D013577:Syndrome
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D009292:Narcotic Antagonists; D011619:Psychotropic Drugs; D000493:Allopurinol
La chimiothérapie des auto-mutilateurs. Remarques et perspectives.